Purpose: Early integration of specialized palliative care (PC) is recommended by clinical guidelines for advanced-stage cancers, but real-world evidence of its use is limited. We examined the recent trend of early PC billing among Medicare beneficiaries with distant-stage cancers and associated provider- and organization-level factors.
Methods: Using SEER-Medicare data, we identified Medicare Fee-For-Service beneficiaries 65.5 years and older diagnosed with distant-stage female breast, colorectal, non-small cell lung, small cell lung, pancreatic, or prostate cancers in 2010-2019 with a survival of ≥6 months. Early PC billing was identified by diagnosis codes or hospice and palliative medicine (HPM) specialty codes on outpatient claims within first 3 months of cancer diagnosis or up to hospice admission date, whichever came first. Annual percentages of patients receiving early PC were assessed. We attributed treating physicians and organizations to patients and identified provider- and organization-level factors associated with early PC billing and the between-provider and between-organization variation in early PC billing using multivariable regressions.
Results: Among 102,032 patients treated by 18,908 unique physicians, the percentage with early PC billing increased from 1.44% to 10.36% in 2010-2019 ( < .001). Treating physician's early PC referrals in the previous year and organizations' employment of any HPM specialist were associated with 3.01 percentage points (ppts, 95% CI, 2.50 to 3.52) and 4.54 ppts (95% CI, 3.65 to 5.42) higher likelihood of early PC billing. Between-provider variation in early PC was considerable but declined from 51.0% in 2010-2013 to 45.3% in 2017-2019. Similar patterns were found for between-organization variation.
Conclusion: Despite growth in early PC billing among patients with distant-stage cancers in 2010-2019, its level remained low. Provider and organizational characteristics such as referral patterns and availability of HPM specialists within the organization may be important drivers for early PC utilization.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1200/JCO-24-01935 | DOI Listing |
JAMA Intern Med
March 2025
Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University, Chicago, Illinois.
Importance: The impact of awake prone positioning (APP) on clinical outcomes in patients with COVID-19 and acute hypoxemic respiratory failure (AHRF) remains uncertain.
Objective: To assess the association of APP with improved clinical outcomes among patients with COVID-19 and AHRF, and to identify potential effect modifiers.
Data Sources: PubMed, Embase, the Cochrane Library, and ClinicalTrials.
J Craniofac Surg
March 2025
Division of Plastic Surgery, Children's Hospital Colorado.
Background: Craniosynostosis requires early diagnosis and intervention to mitigate the risks of impaired cranial growth; however, patients with Medicaid face treatment delays for craniosynostosis care. Medicaid reimbursement rates have failed to match the inflation rate in medicine, remaining relatively static in many surgical fields. This study investigates Medicaid reimbursement and the longitudinal impact of economic inflation on reimbursement for craniosynostosis care.
View Article and Find Full Text PDFJ Clin Oncol
March 2025
Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN.
Purpose: Early integration of specialized palliative care (PC) is recommended by clinical guidelines for advanced-stage cancers, but real-world evidence of its use is limited. We examined the recent trend of early PC billing among Medicare beneficiaries with distant-stage cancers and associated provider- and organization-level factors.
Methods: Using SEER-Medicare data, we identified Medicare Fee-For-Service beneficiaries 65.
JAMA Netw Open
March 2025
Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts.
Importance: Best practices for improving access to assessment of hereditary cancer risk in primary care are lacking.
Objective: To compare 2 population-based engagement strategies for identifying primary care patients with a family or personal history of cancer and offering eligible individuals genetic testing for cancer susceptibility.
Design, Setting, And Participants: The EDGE (Early Detection of Genetic Risk) clinical trial cluster-randomized 12 clinics from 2 health care systems in Montana, Wyoming, and Washington state to 1 of 2 engagement approaches for assessment of hereditary cancer risk in primary care.
Am J Dermatopathol
February 2025
Unité d'Histopathologie et de Mycologie Cutanée, CHU Saint Pierre, ULB, Brussels, Belgium.
Pilomatrical tumors include pilomatricoma, melanocytic matricoma, and pilomatrical carcinoma. Similar to the normal anagen hair follicle bulb, they may be associated with benign and, rarely, with atypical pigmented dendritic melanocytes. It has been recently suggested that the term "melanocytic matricoma" be replaced with "pilomatricoma with melanocytic hyperplasia" (PMMH).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!